Larvol Delta - Study-of-CBL0137-in-Combination-With-Ipilimumab-and-Nivolumab-Therapy-in-Melanoma

Yervoy (ipilimumab) - BMS

CBL0137 - Incuron, Children's Oncology Group

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://clinicaltrials.gov/ct2/show/NCT05498792

May 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next